- This event has passed.
Ben Baker, Clinical Research Scientist, BS, MIPH.
May 4 @ 7:00 pm - 8:00 pm AEST
The Next Generation of Vaccination
Ben has spent the last ten years advancing microneedle vaccination technologies, specifically the Nanopatch™ being developed by Vaxxas. Vaxxas was spun out of the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland in 2011 and has steadily been advancing towards commercialisation since. Ben’s primary interest is in testing Vaxxas’ technology clinically to ensure it performs well and is easy and intuitive to use. He is also dedicated to ensuring Vaxxas’ technology is developed with use in low- and middle-income countries in mind as this is where the technology can have the most transformative impact in saving lives and reducing the burden of infectious disease.